• 353 1 5677201
  • info@irishthoracicsociety.com
Spring Meeting
Linkedin Twitter

Abstracts

Reset
IDCategoryDocument TitleAuthor(s)Institution
1.01 Asthma Don’t act on the ACT Vincent Brennan RCSI View Abstract
1.02 Asthma Inflammatory pathways in severe asthma Vincent Brennan RCSI View Abstract
1.03 Asthma Screening for Hyperglycaemia in Accordance with ‘Joint British Diabetes Societies for inpatient care’ Guidelines in Patients with Acute Asthma Exacerbations Treated with Systemic Corticosteroids in a Single Centre. Alexandra Brickley Cork University Hospital View Abstract
1.04 Asthma Herpes Zoster in Mepolizumab Recipients. To Vax or not to Vax? Tara Byrne HSE/ Saolta Hospital Group View Abstract
1.05 Asthma A Patient Experience Survey of asthma biologic patients self-administering at home under the care of the asthma service at Cork University Hospital. Deborah Casey Cork Uiversity Hospital View Abstract
1.06 Asthma Glycaemic control in outpatients with severe asthma Dominic Doyle Cork University Hospital View Abstract
1.07 Asthma Development of a Novel Pre-clinical Model of House Dust Mite Induced Allergic Airway Inflammation Using Transgenic Mice Expressing Human MIF Hazel Dunbar Maynooth University View Abstract
1.08 Asthma A randomised trial of a T2-composite-biomarker strategy adjusting corticosteroid-treatment in severe asthma, a post- hoc analysis by sex Matthew Chad Eastwood Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, UK View Abstract
1.09 Asthma Asthma patients discharged from the emergency department in Ireland: an unmet need? Cameron Forward Mater Public hospital View Abstract
1.1 Asthma Pulmonary rehabilitation versus usual care for adults with asthma – a Cochrane systematic review Ciara Gleeson St. James's Hospital View Abstract
1.11 Asthma Establishment of a Specialist Respiratory Pharmacist Outpatient Clinic Cairine Gormley Western Health and Social Care Trust View Abstract
1.12 Asthma MIF Enhances Human Mesenchymal Stromal Cell Longevity In Vivo In Allergic Airway Inflammation Ian Hawthorne Maynooth University View Abstract
1.15 Asthma & Sleep Outcomes in at home pulse oximetry in a paediatric respiratory centre Jason Foran University Hospital Limerick View Abstract
1.16 Asthma & Sleep A review of the use of domiciliary non-invasive ventilation in a tertiary hospital Margaret Higgins St. Vincent's University Hospital View Abstract
1.17 Asthma & Sleep Liraglutide-Based Weight Loss versus CPAP Therapy in improving Sleep Quality and Quality of Life of Patients with Obstructive Sleep Apnoea – an Explorative, Proof of Concept Study Cliona O'Donnell St. Vincent's University Hospital View Abstract
1.18 Asthma & Sleep Are we doing the necessary investigations to monitor for cardiometabolic risk factors in confirmed cases of obstructive sleep apnoea in our centre? Aoife Power Tallaght University Hospital View Abstract
1.19 Asthma & Sleep Management and Outcomes of Mild OSA (AHI 5-15): A Real-World Study Romina Golchin University College Cork View Abstract
1.21 Asthma & Sleep Non-CPAP therapies in the treatment of Obstructive Sleep Apnoea Ciara McLoughlin Bons Secours Hospital Cork View Abstract
1.22 Asthma & Sleep Home Sleep Apnoea Testing: Optimising Patient Outcome with Limited Resources Orla Wynne Tallaght University Hospital View Abstract
2.01 COPD Establishing Diurnal Variation of Inflammatory Markers in Genetic COPD Lameese Alhaddah RCSI View Abstract
2.02 COPD Serum Eosinophils in Patients with Chronic Obstructive Pulmonary Disease (COPD) Attending Our Lady of Lourdes Hospital (OLOL) Arsah Asis Our Lady of Lourdes Hospital, Drogheda View Abstract
2.03 COPD What effect does home-based management have on COPD patients’ hospital & readmission rates Rita Corcoran CHW Mayo, HSE View Abstract
2.04 COPD Carbon Emissions, Sedentary Travel Time and Mode of Transport to a Community-Based Multi-Site Pulmonary Rehab Program Sinéad Delahunty South Tipperary Community Specialist Respiratory Team, Integrated Care Programme for Chronic Disease, HSE View Abstract
2.05 COPD Pre and Post Pandemic Exercise Capacity and Symptom Burden in Chronic Obstructive Pulmonary Disease Elizabeth Dunphy St Michael's Hospital, Dun Laoghaire View Abstract
2.06 COPD Mapping behaviour change interventions for physical activity behaviour in chronic obstructive pulmonary disease to the Theoretical Domains Framework: a systematic review and meta-analysis Ciara Hanrahan University College Cork View Abstract
2.07 COPD A review of Azithromycin Prophylaxis; Appropriateness of Initial Prescription and Safety Monitoring Daphne Masterson ICPCD, South Tipperary View Abstract
2.08 COPD Steroid Prescribing Practices in Acute COPD Exacerbations– An Audit of a Level 3 Irish Hospital Mary Mc Namee St Vincent's University Hospital, Elm Park View Abstract
2.09 COPD A Micro-Costing Analysis of Lung Volume Reduction Surgery from a National Tertiary Referral Centre Kathryn Mulryan Mater Hospital View Abstract
2.11 COPD Can Pulmonary Rehabilitation (PR) Resolve Sarcopenia in patients with Chronic Lung Disease? Catherine Speirs Ballinasloe Chronic Disease Hub View Abstract
2.12 COPD An Audit on Compliance with COPD Guidelines in Midlands Regional Hospital, Tullamore Eleanor Cronin Midlands Regional Hospital, Tullamore View Abstract
2.13 COPD How pulmonary rehabilitation influences Frailty as measured using the Clinical Frailty Scale (CFS) Niamh Duignan HSE Galway city integrated care hub View Abstract
2.14 COPD A new initiative: Progressive Resistance Training (PRT) in patients with Chronic Obstructive Pulmonary Disease (COPD) in Pulmonary Rehabilitation (PR) exercise class Rachel Egan Tallaght University Hospital View Abstract
2.15 COPD Alpha-1 Antitrypsin Deficiency: Evaluating the Effectiveness of Health-Related Quality of Life Data in Tracking Disease Severity and Progression Mariam Ghoneem Royal College of Surgeons in Irealnd View Abstract
2.16 COPD Don’t ignore the nonsense: Alpha-1 Antitrypsin Deficiency caused by null mutations Ronan Heeney RCSI View Abstract
2.17 COPD Implementation of Azithromycin Prophylaxis Guidance in Our Lady of Lourdes Hospital, Drogheda Viji Mathew Our Lady of Lourdes Hospital View Abstract
2.18 COPD Exploring Metal-Derived Therapeutics For Combating COPD Exacerbations Megan O'Shaughnessy Trinity College Dublin View Abstract
2.18 Interstitial Lung Disease An overview of the combined palliative care – interstitial lung disease multidisciplinary meeting in a tertiary hospital Liam Chawke Mater Misericordiae University Hospital View Abstract
2.19 COPD Physical Activity, Exercise Capacity and Sedentary Behaviour in People with Alpha-1 Antitrypsin Deficiency: A Scoping Review Orlagh O'Shea RCSI View Abstract
2.21 COPD Effectiveness of COPD Support Ireland-delivered exercise classes in maintaining symptoms and functional status   Joan Johnston COPD Support Ireland View Abstract
3.01 General Respiratory 1 Setting up a new Continuous Laryngoscopy during Exercise (CLE) service for the diagnosis of Exercise Induced Laryngeal Obstruction (EILO) at Connolly Hospital, Dublin Aisling McGowan Connolly Hospital View Abstract
3.02 General Respiratory 1 An evaluation of physician-diagnosed airways disease versus physiological confirmation Barry Moran St. Vincent's University Hospital, Elm Park, Dublin 4. View Abstract
3.03 General Respiratory 1 Inpatient Management of pulmonary embolism as per NICE guidelines Zaheer Aslam Bedford Hospital NHS foundation trust View Abstract
3.04 General Respiratory 1 Yield of CTPA in the diagnosis of Acute Pulmonary Embolism: A Single Centre Experience Antonia Harold-Barry RCPI Basic Specialist Training Scheme - South Hub View Abstract
3.05 General Respiratory 1 1st Irish National Pulmonary Hypertension Audit – 2021-2022 Margaret Higgins Mater Misericordiae University Hospital View Abstract
3.06 General Respiratory 1 Alpha-1 Antitrypsin ameliorates lung injury in an ex vivo model of Acute Respiratory Distress Syndrome Grace Hogan RCSI View Abstract
3.08 General Respiratory 1 NICE Guidelines followed for patients presenting with suspected Pulmonary Embolism in Naas General Hospital Sahib Khan Naas General Hospital, Naas, Co. Kildare View Abstract
3.09 General Respiratory 1 Outcomes from a Respiratory Ambulatory Assessment Unit in a District General Hospital Margaret Mccloskey altnagelvin area hospital View Abstract
3.11 General Respiratory 1 A prospective audit of chest x-ray reporting accuracy by non-consultant hospital doctors (NCHDs): A comparison between in-hours and out-of-hours shifts during one week of acute medical admissions – St Lukes’ General Hospital Kilkenny Robert Allan Murphy St Lukes Hospital, Kilkenny View Abstract
3.12 General Respiratory 1 DASH score for recurrent VTE-Retrospective study Sarmad Mushtaq Princess Alexandra Hospital NHS trust View Abstract
3.13 General Respiratory 1 Clinical Audit of Pulmonary Embolism (PE) management at discharge in a tertiary referral centre James O'Hanlon Beaumont Hospital View Abstract
3.14 General Respiratory 1 CTPA in Pregnancy: A Refresher on Risk Vs Reward James O'Regan Cork University Hospital View Abstract
3.15 General Respiratory 1 Learnings From the First 18 months of a Novel Cross-Site Multi-Disciplinary Pulmonary Pregnancy Service Dorothy Ryan Beaumont Hospital, Dublin, Ireland View Abstract
3.16 General Respiratory 1 Impact of Respiratory Clinical Nurse Specialist attendance in a General Respiratory Clinic Michelle Uno Our Lady of Lourdes Hospital Drogheda View Abstract
3.17 General Respiratory 1 Patients’ Reported Reasons of Non-Attendance in a Respiratory Outpatient Services Michelle Uno Our Lady of Lourdes Hospital Drogheda View Abstract
3.18 General Respiratory 1 Prevalence of sarcopenia and frailty in patients admitted to a respiratory inpatient rehabilitation unit Elaine Cribbin Peamount Healthcare View Abstract
3.19 General Respiratory 1 Establishing a Breathing Pattern Disorder clinic, a Respiratory Integrated Care physiotherapy experience Danielle Moynihan Chronic Disease Hub, CHO 5, HSE South East Community Healthcare, James’ Green, Kilkenny View Abstract
3.21 General Respiratory 1 An audit of ventilation perfusion imaging in patients with connective tissue disease associated pulmonary arterial hypertension Eoin Rigney Mater Misericordiae University Hospital View Abstract
3.22 General Respiratory 1 Investigating the role of the Acute Respiratory Distress Syndrome disease micro-environment on human bone-marrow derived Mesenchymal Stromal Cells Courteney Tunstead Maynooth University View Abstract
4.01 ILD & Long Covid Experience of a National Rare Lung Disease Clinic Andrew Clarke St Vincents Hospital View Abstract
4.02 ILD & Long Covid P2 receptor expression profiles in circulating and airway cells in Idiopathic Pulmonary Fibrosis Luke Forde RCSI (OCPE) View Abstract
4.03 ILD & Long Covid 5-year observational study of deaths in the ILD cohort in a specialist centre Dhiviya Ganesan Galway University Hospital View Abstract
4.04 ILD & Long Covid BREATHE – Bringing Resourcing, Empowerment and Awareness To the Home Environment: Patients’ Perception of Home Spirometry and Oximetry Monitoring for Connective Tissue Disease related Interstitial Lung Disease Wan Lin Ng Beaumont Hospital View Abstract
4.05 ILD & Long Covid The role of Immunoglobulin A in the pathogenesis of Idiopathic pulmonary fibrosis, A literature review Joshua Olaniyi University of South Wales View Abstract
4.06 ILD & Long Covid Presentation, mode of diagnosis and management of pulmonary alveolar proteinosis syndrome in an Irish population Maitreyi Penugonda St. Vincent's University Hospital View Abstract
4.07 ILD & Long Covid Hypoxia-stimulated Human Epididymis Protein 4 (HE4) Secretion by Bronchial Epithelial Cells and its Effect on Pulmonary Fibroblasts Koray Potel Queen's University Belfast View Abstract
4.08 ILD & Long Covid A scoping review of the unmet needs of patients diagnosed with idiopathic pulmonary fibrosis (IPF) Carita Bramhill Trinity College Dublin View Abstract
4.09 ILD & Long Covid An audit of access to diagnostics in a specialised connective tissue disease-associated interstitial lung disease shared care clinic Sean Garvey Cork University Hospital View Abstract
4.11 ILD & Long Covid Interstitial Lung Disease (ILD) Service Naas General Hospital (NGH) Olivia Lee Naas General Hospital View Abstract
4.12 ILD & Long Covid A retrospective review of pulmonary rehabilitation outcomes in Interstitial Lung Disease Grace O'Sullivan Cork University Hospital View Abstract
4.13 ILD & Long Covid An audit of access and barriers to palliative care services in deceased patients known to the interstitial lung disease service Eoin Rigney Mater Misericordiae University Hospital View Abstract
4.14 ILD & Long Covid A Review and Audit of the Pulmonary Fibrosis Nurse Led Clinic within the UHL Hospital Group Carmel McINerney University Hospital Limerick, Ennis and Nenagh Hospital View Abstract
4.15 ILD & Long Covid A Review of Pulmonary Fibrosis Patients Journey of the Advanced Nurse Practitioner Satellite Clinic Paula Ryan University Hospital Limerick, Ennis and Nenagh Hospital View Abstract
4.16 ILD & Long Covid Perfenidone vs Nintedanib for Idiopathic Pulmonary Fibrosis – an Observational study at a Teaching Hospital in Republic of Ireland Junaid Rasul Awan University Hospital Limerick View Abstract
4.17 ILD & Long Covid The Prevalence of Post-Covid Interstitial Lung Disease in A Tertiary, Single Centre Hospital in Ireland Arsah Asis Our Lady of Lourdes Hospital, Drogheda View Abstract
4.18 ILD & Long Covid Respiratory Symptoms at the Long COVID clinic: Are Further Investigations Required? Rachel Christner Galway University Hospital View Abstract
4.19 ILD & Long Covid Investigation of the role of the toll-like receptor 3 (TLR3) Leu412Phe (TLR3 L412F) single nucleotide polymorphism in the pathogenesis of long COVID Thomas J. Butler Trinity College Dublin View Abstract
5.01 Telehealth & Smoking A pilot of digital technology innovation for video Direct Observation of Therapy (v-DOT) in adult asthma patients Martin Kelly Altnagelvin Area Hospital, Western Trust View Abstract
5.02 Telehealth & Smoking Utilising digital technology in the diagnosis of patients with suspected asthma Patrick Kerr RCSI & Bon Secours Hospital View Abstract
5.03 Telehealth & Smoking Community Virtual Pulmonary Rehabilitation Advancements in the Mid-West Mairghread Moynihan HSE CDM Respiratory Integrated Care View Abstract
5.04 Telehealth & Smoking Enhanced identification and stratification of patients with COPD using a digitallyinnovative data platform solution in General Practice Thomas Hughes IQVIA View Abstract
5.05 Telehealth & Smoking A virtual COPD management programme using remote monitoring to reduce acute healthcare utilisation Sarah Nolan Our Lady of Lourdes Hospital View Abstract
5.06 Telehealth & Smoking Assessing the impact of a remote monitoring virtual COPD management programme one year on Sarah Nolan Our Lady of Lourdes Hospital View Abstract
5.07 Telehealth & Smoking A mixed methodology study to determine indicative key performance indicators that will support, inform and harmonise appropriate use and development of digital health technologies for respiratory patient usage Tara Byrne Saolta Hospital Group View Abstract
5.08 Telehealth & Smoking Bespoke 3D printed attachment to deliver CPAP to a patient with a laryngectomy Ciara Dolan University Hospital Galway View Abstract
5.09 Telehealth & Smoking Overview of an Electronic Respiratory Inpatient Referral System in a District General Hospital Margaret Mccloskey altnagelvin area hospital View Abstract
5.11 Telehealth & Smoking Introduction of a New Virtual Respiratory Patient Board Meeting in Tallaght University Hospital Judith Maxwell Tallaght University Hospital View Abstract
6.01 Oral Presentations 1 Prevalence and Clinical Characteristics of LAM in an Irish Cohort Maitreyi Penugonda St. Vincent's University Hospital, Dublin View Abstract
6.02 Oral Presentations 1 Pharmaceutical Modifications of Human Epididymis Protein 4 (HE4) has Antifibrotic and Anti-Inflammatory Effects on lung fibrosis Bettina Schock Queen's University Belfast View Abstract
6.03 Oral Presentations 1 Induced Pluripotent Stem Cell-derived Alveolar Epithelial Type 2 Cells – A Novel Model to investigate Sex Hormones and their Role in Pulmonary Fibrosis Anja Schweikert Royal College of Surgeons in Ireland View Abstract
6.04 Oral Presentations 1 An adenoviral COVID-19 vaccine enhances monocyte responses to Mycobacterium tuberculosis. Dearbhla Murphy Trinity College Dubin View Abstract
6.05 Oral Presentations 1 The Potential Impact of Sublobar Resection for NSCLC Management in an Irish Setting Rebecca Weedle St James's Hospital, Dublin View Abstract
7.01 Integrated Care Exploring the effectiveness of a Joint Cardiology-Respiratory Clinic as a Greener Healthcare Method Amy Anderson Dublin North West Integrated Care Service View Abstract
7.02 Integrated Care Respiratory Diagnostics incorporating a detailed Diagnostic Review and Report Rachel Anglin St Vincent's University Hospital View Abstract
7.03 Integrated Care NIMIS Project connecting Connolly Hospital Respiratory Diagnostics services to the new Dublin North West Community Integrated Care Hub diagnostics services in CHO9 Louise Brien Connolly Hospital View Abstract
7.04 Integrated Care PR Plus+: Maintenance programmes following Pulmonary Rehabilitation: The patient perspective Roisin Cahalan University of Limerick View Abstract
7.05 Integrated Care Respiratory Waitlist Initiative Clinic: a blueprint for the integrated care hubs? Rachel Christner Galway University Hospital View Abstract
7.06 Integrated Care Mid-West Integrated Care GP Access Respiratory Clinic: A Service Evaluation Brian Fitzgibbon HSE Midwest Community Healthcare View Abstract
7.07 Integrated Care An assessment of the ‘one-stop-shop’ community respiratory clinics to optimise COPD and asthma management Dhiviya Ganesan Galway University Hospital View Abstract
7.08 Integrated Care Evaluation of GP direct access to spirometry in Galway City Integrated Care Hub Dhiviya Ganesan Galway University Hospital View Abstract
7.09 Integrated Care Integrated Cardiopulmonary Specialist Care – A Novel Approach Isra Hussein Connolly Hospital View Abstract

ITS

Irish Thoracic Society


Registered Charity No: CHY 17510

Privacy Policy

51 Bracken Road, Sandyford Business Park
Dublin 18, D18 CV48

© Irish Thoracic Society 2024